Zatorski Nicole, Schlessinger Avner
Duke University Hospital.
Icahn School of Medicine at Mount Sinai.
Res Sq. 2025 Jul 10:rs.3.rs-6999821. doi: 10.21203/rs.3.rs-6999821/v1.
Despite rigorous safety evaluations during development, numerous drugs have been withdrawn from the market due to serious toxicities. Here we investigate the features found in drugs with these unanticipated toxicities and apply a machine learning approach to predict if a drug is likely to be withdrawn due to intolerable side effects without the need for human trial data. Our best preforming classifier was an ensemble predictor trained on protein targets, protein structure features, chemical fingerprints, and chemical features that achieved 92% accuracy and 0.845 Matthews Correlation Coefficient with 10-fold holdout test set cross validation. Analysis of features predictive of unanticipated toxicity revealed both known factors such as inhibition of cytochrome P450 as well as yet uninvestigated factors including the inhibition of bile salt export pumps. This predictor and subsequent feature analysis pave the way for the larger role of computational methods in screening potential candidates during drug development.
尽管在研发过程中进行了严格的安全性评估,但仍有许多药物因严重毒性而被撤出市场。在此,我们研究了具有这些意外毒性的药物所具有的特征,并应用机器学习方法来预测一种药物是否可能因无法耐受的副作用而被撤出,而无需人体试验数据。我们表现最佳的分类器是一个集成预测器,它基于蛋白质靶点、蛋白质结构特征、化学指纹和化学特征进行训练,在10倍留出测试集交叉验证中达到了92%的准确率和0.845的马修斯相关系数。对意外毒性预测特征的分析揭示了诸如抑制细胞色素P450等已知因素,以及包括抑制胆盐输出泵在内的尚未研究的因素。这种预测器及后续的特征分析为计算方法在药物研发过程中筛选潜在候选药物方面发挥更大作用铺平了道路。